Literature DB >> 25890574

Local hypoxia in oral mucosa (mouse) during daily fractionated irradiation - Effect of pentoxifylline.

Sylvia Gruber1, Daniel Hamedinger2, Eva Bozsaky1, Margret Schmidt3, Kathrin Wolfram4, Julia Haagen4, Bettina Habelt4, Martin Puttrich4, Wolfgang Dörr5.   

Abstract

PURPOSE: A significant reduction of radiation-induced oral mucositis by systemic application of pentoxifylline has been demonstrated in a mouse tongue model. However, the underlying mechanisms remain unclear. The present study focuses on the development of local hypoxia in mouse tongue during daily fractionated irradiation and a potential modulation by pentoxifylline.
MATERIALS AND METHODS: Daily fractionated irradiation with 5×3Gy/week (days 0-4, 7-11) was given to the snouts of mice. Groups of 3 animals per day were sacrificed between day 0 and 14. Pentoxifylline (15mg/kg, s.c.) was administered daily from day -5 to the day before the mice were sacrificed. The expression of intrinsic hypoxia markers HIF-1α and GLUT1 in the epithelium of the lower tongue surface was analysed by immunohistochemistry in 3 animals per day; the percentage of positive epithelial cells and the staining intensity were analysed as endpoints.
RESULTS: Compared to untreated control tissue, fractionated irradiation resulted in a progressive increase in the expression of both hypoxia markers. This effect was significantly reduced by pentoxifylline.
CONCLUSION: An early onset of local hypoxia occurs during fractionated irradiation in mouse tongue epithelium. The effect is markedly reduced by the mucoprotective agent pentoxifylline, suggesting a mucositis-promoting role of hypoxia; this, however, deserves further investigation.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  fractionated irradiation; hypoxia; mouse model; oral mucositis; pentoxifylline

Mesh:

Substances:

Year:  2015        PMID: 25890574     DOI: 10.1016/j.radonc.2015.03.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

Review 1.  The pathogenesis of mucositis: updated perspectives and emerging targets.

Authors:  J Bowen; N Al-Dasooqi; P Bossi; H Wardill; Y Van Sebille; A Al-Azri; E Bateman; M E Correa; J Raber-Durlacher; A Kandwal; B Mayo; R G Nair; A Stringer; K Ten Bohmer; D Thorpe; R V Lalla; S Sonis; K Cheng; S Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

2.  Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy.

Authors:  Jon Kirk; Nirav Shah; Braxton Noll; Craig B Stevens; Marshall Lawler; Farah B Mougeot; Jean-Luc C Mougeot
Journal:  Support Care Cancer       Date:  2018-02-23       Impact factor: 3.603

3.  Early inflammatory changes in radiation-induced oral mucositis : Effect of pentoxifylline in a mouse model.

Authors:  Sylvia Gruber; Eva Bozsaky; Eva Roitinger; Karoline Schwarz; Margret Schmidt; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2017-03-03       Impact factor: 3.621

4.  Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation.

Authors:  Sylvia Gruber; Marlene Arnold; Nilsu Cini; Victoria Gernedl; Sabine Hetzendorfer; Lisa-Marie Kowald; Peter Kuess; Julia Mayer; Susanne Morava; Stephanie Pfaffinger; Andreas Rohorzka; Wolfgang Dörr
Journal:  Int J Mol Sci       Date:  2018-06-06       Impact factor: 5.923

5.  Protective effects of systemic dermatan sulfate treatment in a preclinical model of radiation-induced oral mucositis.

Authors:  Sylvia Gruber; Katharina Frings; Peter Kuess; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2018-03-01       Impact factor: 3.621

6.  Alpha lipoic acid attenuates radiation-induced oral mucositis in rats.

Authors:  Jin Hyun Kim; Myeong Hee Jung; Jin Pyeong Kim; Hyun-Jung Kim; Jung Hwa Jung; Jong Ryeal Hahm; Ki Mun Kang; Bae-Kwon Jeong; Seung Hoon Woo
Journal:  Oncotarget       Date:  2017-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.